The Angels announced on Monday that outfielder Mike Trout underwent a cryoablation procedure to address a neuroma in his right foot. He’s considered day-to-day and hopes to return in a couple of days. Trout exited Friday’s game after five innings and only pinch-hit on Saturday before sitting out all of Sunday’s action.
Per MLB.com’s Rhett Bollinger, manager Brad Ausmus said, “I’m not in the medical field, but it’s a buildup of tissue around the nerve that causes pain. Today, he had a cryoablation that deadens the tissue, deadens the nerve area.”
Trout, 28, is the prohibitive favorite for the AL MVP Award, batting .291/.438/.645 with 45 home runs, 104 RBI, 110 runs scored, and 11 stolen bases in 600 plate appearances. FanGraphs credits him with 8.7 WAR, which is 1.7 more than his closest competitor, Astros 3B/SS Alex Bregman.
ESPN’s Jeff Passan reports that the Rockies and shortstop Trevor Story have come to terms on a two-year, $27.5 million deal, buying out his two remaining years of arbitration eligibility.
Story, 27, and the Rockies did not agree on a salary before the deadline earlier this month. Story filed for $11.5 million while the team countered at $10.75 million. The average annual value of this deal — $13.75 million — puts him a little bit ahead this year and likely a little bit behind next year.
This past season in Colorado, Story hit .294/.363/.554 with 35 home runs, 85 RBI, 111 runs scored, and 23 stolen bases over 656 trips to the plate. He also continued to rank among the game’s best defensive shortstops. Per FanGraphs, Story’s 10.9 Wins Above Replacement over the last two seasons is fifth-best among shortstops (min. 1,000 PA) behind Alex Bregman, Francisco Lindor, Xander Bogaerts, and Marcus Semien.
With third baseman Nolan Arenado likely on his way out via trade, one wonders if the same fate awaits Story at some point over the next two seasons.